Cover Image
市場調查報告書

全球寵物醫療市場:各產品(疫苗,寄生蟲驅除劑,抗發炎藥,醫療用食品添加物,其他的醫藥品),診斷技術,動物(狗,貓,馬),地區 - 趨勢及預測

Companion Animal Health Market By Products (Vaccines, Paraciticides, Anti-Infectives, Medicinal Feed Additives, And Other Pharmaceuticals), By Diagnostic Technologies, By Animals Type (Dogs, Cats And Horses), By Geography-Trends And Forecast (2016-2021)

出版商 Mordor Intelligence LLP 商品編碼 319394
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
全球寵物醫療市場:各產品(疫苗,寄生蟲驅除劑,抗發炎藥,醫療用食品添加物,其他的醫藥品),診斷技術,動物(狗,貓,馬),地區 - 趨勢及預測 Companion Animal Health Market By Products (Vaccines, Paraciticides, Anti-Infectives, Medicinal Feed Additives, And Other Pharmaceuticals), By Diagnostic Technologies, By Animals Type (Dogs, Cats And Horses), By Geography-Trends And Forecast (2016-2021)
出版日期: 2016年01月01日 內容資訊: 英文
簡介

全球寵物醫療市場在2013年為85億美元規模。一般認為該市場今後將以年複合成長率7.86%持續成長,到2019年將達到133億7,000萬美元的規模。

本報告提供全球寵物醫療市場現況與未來預測,提供您各市場區隔,各地區趨勢,並彙整主要的參與企業競爭環境與簡介等資料。

第1章 簡介

第2章 市場分析

  • 動物醫療產品
  • 動物醫療和人的醫療

第3章 市場趨勢

  • 推動市場的要素
    • 寵物飼主感情
    • 營養的改善
    • 消費者對食品安全性的注意力提升
    • 飼料的增產
    • 動物平原性傳染病及透過食物傳染的疾病
  • 阻礙市場的要素
    • 耕地和水的危機
    • 耕地的競爭激烈
    • 成本效益高的生產
  • 波特五力分析

第4章 市場區隔

  • 各產品
    • 寄生蟲驅除劑
    • 抗發炎藥
    • 醫療用食品添加物
    • 其他的醫藥品
    • 疫苗
  • 寵物

第5章 全球寵物診斷藥市場

  • 酵素連結免疫吸附法(ELISA)
  • Rapid Immuno Migration( RIM)
  • Agar gel Immuno Diffusion( AGID)

第6章 全球寵物遺傳學市場

第7章 各地區市場市場區隔

  • 北美
  • 歐洲
  • 亞太地區

第8章 競爭環境

  • 市場上主要企業
  • 合併·收購
  • 新產品上市
  • 協定,聯合,夥伴關係
  • 其他

第9章 企業簡介

  • Zoetis animal healthcare
  • Merck
  • Merial
  • Elanco
  • Bayer healthcare
  • Novartis Animal Health, Inc.
  • Virbac
  • Boehringer Ingelheim

第10章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

The global market for companion animal healthcare is valued at USD 9.8 billion in 2015 and it is projected to reach USD 14.43 billion by 2020 at a CAGR of 7.86% during the forecast period 2015-2020.

Veterinary healthcare deals with food safety; prevention, diagnosis and treatment of diseases, disorders or any injuries in animals and consistently monitoring the health of animals. In United States alone, Americans spent more than USD 53 billion on food, pet supplies, over-the-counter and prescription medications, veterinary care, live animal purchases, and other pet-related services.

The end-user market is segmented into veterinary hospitals, clinics and reference laboratories. Veterinary Hospitals and clinics are the major sub segments contributing to the economic growth of this market. Pet owners/lovers utilize the animal health services provided by physicians or care providers.

Rising incidence of diseases (food-borne and zoonotic) in animals which consequently transfer to human beings and awareness for animal health, are the major driving factors for the market. Another factor that drives the market is continuous innovations and technological advances in development of animal health drugs. On other hand, Scarcity of arable land and water, increased competition for cultivated land and Cost effective production are constraining the growth of this market.

The companion animal health market is segmented based on Product type, Animal Diagnostics and Animal Genetics. Animal products segment includes Vaccines, Parasiticides, Anti-infectives, Feed additives and Pharmaceuticals. Feed additives is further segmented into Nutritional Feed Additives and Medicinal Feed Additives. Animal diagnostics segment includes Enzyme Linked Immuno Sorbent Assay (ELISA), Rapid Immuno Migration (RIM) and Agar Gel Immuno Diffusion (AGID). The genetics segment includes sub-segments like HD 50K for Angus, CLARIFIDE® for Dairy, Sheep 50K and CLARIFIDE® for Nelore.

Based on geography, the market is divided into North America, Asia-Pacific, Europe and Rest of World. Europe accounts for the largest share of the animal vaccines market, followed by North America. The developing regions like Asia-pacific and Africa are expected to form a new revenue pocket in the market. Countries such as India, China, and Brazil will be the major contributors in the market.

Pfizer (U.S.), Merck (U.S.), Sanofi-Aventis (France), Bayer HealthCare (Germany), Virbac (France), Novartis (Switzerland), Boehringer Ingelheim (Germany), Heska Corporation (U.S.), Bioniche Animal Health Canada, Inc. (Canada), and Ceva (France) are the key players in the global companion animal health market

Key Deliverables in the Study

  • 1. Market analysis for the Global Companion Animal healthcare Market, with region specific assessments and competition analysis on global and regional scales
  • 2. Market definition along with the identification of key drivers and restraints
  • 3. Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale
  • 4. Extensively researched competitive landscape section with profiles of major companies along with their market shares
  • 5. Identification and analysis of the macro and micro factors that affect the Global Companion Animal healthcare Market on both global and regional scales
  • 6. A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information
  • 7. A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market
  • 8. Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped

Table of Contents

  • Introduction
  • Study Deliverables
  • Market Definition
  • Sizing Units
  • Base Currency
  • Review and Forecast Period Years
  • General Study Assumptions
  • Research Methodology
  • Introduction
  • Analysis Methodology
  • Econometric Forecast Model
  • Research Assumptions
  • Executive Summary
  • Key Inferences
  • Market Overview and Industry Trends
  • Current Market Scenario
  • Applications of Companion Animal Healthcare
  • Technology Overview
  • New Developments
  • Industry Value-Chain Analysis
  • Product Life-Cycle Analysis
  • Product Benchmarking
  • Investment Analysis
  • Porter's Five Forces
  • Bargaining Power of Suppliers
  • Bargaining Power of Consumers
  • Threat of New Entrants
  • Threat of Substitute Products and Services
  • Competitive Rivalry within the Industry
  • Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
  • Market Drivers
  • Rising incidence of diseases (food-borne and zoonotic) in animals
  • Awareness for animal health
  • Continuous innovations and technological advances in development of animal health drug
  • Market Restraints
  • Increased competition for cultivated land
  • Cost effective production
  • Scarcity of arable land and water
  • Key Challenges
  • Current Opportunities in the Market
  • Market Segmentation
  • By Product type
  • Vaccines
  • Parasiticides
  • Anti-infectives
  • Feed additives
  • Nutritional Feed Additives
  • Medicinal Feed Additives
  • Pharmaceuticals
  • By Animal diagnostics
  • Enzyme Linked Immuno Sorbent Assay (ELISA)
  • Rapid Immuno Migration (RIM)
  • Agar Gel Immuno Diffusion (AGID)
  • By End-User
  • Veterinary Hospitals
  • Clinics
  • Reference laboratories
  • By Geography
  • North America
  • Introduction
  • US
  • Canada
  • Mexico
  • Europe
  • Introduction
  • France
  • UK
  • Germany
  • Italy
  • Spain
  • Asia-Pacific
  • Introduction
  • India
  • China
  • Japan
  • Australia & New Zealand
  • South Korea
  • Middle-East and North Africa (MENA)
  • Introduction
  • GCC
  • Egypt
  • Algeria
  • South America
  • Introduction
  • Brazil
  • Argentina
  • Others
  • Competitive Landscape
  • Merger and Acquisition Analysis
  • New Product Launches
  • Agreements, Collaborations & Partnerships

    9. Company Profiles

  • Pfizer
  • Merck
  • Sanofi-Aventis
  • Bayer HealthCare
  • Virbac
  • Novartis
  • Boehringer Ingelheim
  • Heska Corporation
  • Bioniche Animal Health Canada, Inc.
  • Ceva
  • Analyst Outlook for Investment Opportunities
  • Future Outlook of the Market
Back to Top